Zining Wang Selected Research

Zining Wang Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 01/2019
9	Hemorrhage 01/2023 - 04/2017
4	Virus Diseases (Viral Diseases) 01/2023 - 01/2016
3	Acute Coronary Syndrome 01/2023 - 01/2020
3	Atrial Fibrillation 01/2023 - 02/2022
3	Bites and Stings (Sting) 01/2022 - 01/2019
3	Thrombosis (Thrombus) 12/2021 - 04/2017
2	Disease Progression 01/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2022
2	Stroke (Strokes) 12/2021 - 01/2019
1	Hypoxia (Hypoxemia) 04/2024
1	Circulating Neoplastic Cells 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024
1	Breast Neoplasms (Breast Cancer) 03/2024
1	Atherosclerosis 02/2024
1	Turcot syndrome 02/2024
1	Inflammation (Inflammations) 02/2024
1	Colonic Neoplasms (Colon Cancer) 02/2024
1	Colorectal Neoplasms (Colorectal Cancer) 02/2024
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2023
1	Ovarian Neoplasms (Ovarian Cancer) 11/2022
1	COVID-19 01/2022
1	Adenocarcinoma 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Ischemic Stroke 12/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Myocardial Infarction 01/2021
1	Venous Thromboembolism 10/2020
1	Hypercholesterolemia 01/2020
1	Injection Site Reaction 01/2020

Drug/Important Bio-Agent (IBA)

4	RivaroxabanIBA 01/2023 - 10/2020
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2019
3	LipidsIBA 02/2024 - 01/2020
3	TicagrelorIBA 01/2023 - 04/2017
3	Dabigatran FDA Link 12/2022 - 10/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2012
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2022
2	NanovaccinesIBA 01/2023 - 01/2021
2	Interferon Type IIBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 01/2019
2	VaccinesIBA 01/2022 - 01/2021
2	apixabanIBA 12/2021 - 10/2020
2	AntigensIBA 01/2021 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2016
2	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2019 - 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Thrombopoietin ReceptorsIBA 04/2023
1	Thrombopoietin (c-mpl Ligand)IBA 04/2023
1	Inosine Triphosphate (ITP)IBA 04/2023
1	Coloring Agents (Dyes)IBA 02/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Cilostazol (Pletal)FDA LinkGeneric 12/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022
1	InterferonsIBA 11/2022
1	Tannic Acid FDA Link 10/2022
1	polydopamineIBA 10/2022
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 10/2022
1	Free RadicalsIBA 10/2022
1	Glutathione (Reduced Glutathione)IBA 10/2022
1	MetalsIBA 10/2022
1	Hyaluronic Acid (Hyaluronan)IBA 10/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	toripalimabIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Drug CombinationsIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	CytokinesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2022
1	AnticoagulantsIBA 12/2021
1	Vitamin K FDA Link 12/2021
1	edoxabanIBA 12/2021
1	Factor Xa (Coagulation Factor Xa)IBA 11/2021
1	Clotrimazole (Lotrimin)FDA LinkGeneric 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	LectinsIBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Factor IIaIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 10/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	SubtilisinIBA 01/2020
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2020
1	Enalapril FDA LinkGeneric 01/2020
1	BradykininIBA 01/2020

Therapy/Procedure

8	Therapeutics 03/2024 - 04/2017
7	Immunotherapy 02/2024 - 01/2019
4	Percutaneous Coronary Intervention 01/2023 - 01/2019
3	Stents 01/2021 - 04/2017